BioPlus Acquisition Corp. (BIOS)
BioPlus Acquisition Statistics
Share Statistics
BioPlus Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.
| n/a |
| 0% |
| 0% |
| n/a |
| n/a |
| 100 |
| 0.28% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is 1183.3 and the forward PE ratio is null. BioPlus Acquisition's PEG ratio is -8.53.
| 1183.3 |
| n/a |
| 0 |
| n/a |
| 27.4 |
| -8835.49 |
| -8.53 |
Enterprise Valuation
BioPlus Acquisition has an Enterprise Value (EV) of 6.11B.
| 0 |
| -5220.56 |
| -8842.52 |
| -8842.52 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.02.
| 1.04 |
| 1.04 |
| 0.02 |
| -4.27 |
| -7.23 |
| 0.37 |
Financial Efficiency
Return on Equity is 2.32% and Return on Invested Capital is -1.33%.
| 2.32% |
| 2.17% |
| -1.33% |
| n/a |
| n/a |
| undefined |
| 0 |
| n/a |
Taxes
| -3.17M |
| -158.68% |
Stock Price Statistics
The stock price has increased by -0.09% in the last 52 weeks. The beta is 0, so BioPlus Acquisition's price volatility has been lower than the market average.
| 0 |
| -0.09% |
| 10.77 |
| 10.54 |
| 51.09 |
| 35,934 |
Balance Sheet
The company has 140.3K in cash and 5M in debt, giving a net cash position of -4.86M.
| 140.3K |
| 5M |
| -4.86M |
| -14.78M |
| 138.63M |
| -1.78M |
Cash Flow
In the last 12 months, operating cash flow was -691.47K and capital expenditures 0, giving a free cash flow of -691.47K.
| -691.47K |
| n/a |
| -691.47K |
| 0 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
BIOS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 0.08% |
| -0.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 7.26 |
| 3 |